##  [US-based Biotechnology Company - Driving IND Success, Regional Continuity, and Rapid Scale-Up for Global Market Submissions](/index%2ephp/case-studies/us-based-biotechnology-company-driving-ind-success-regional-continuity-and-rapid-scale-up-for-global-market-submissions) 

- [Medicinal Products](/index%2ephp/case-studies-main-categories/medicinal-products)
- [Publishing and Submission](/index%2ephp/case-studies-main-categories/publishing-and-submission)





[US FDA](/index%2ephp/case-studies-heath-authority/us-fda)

 

 ![US-based Biotechnology Company - Driving IND Success, Regional Continuity, and Rapid Scale-Up for Global Market Submissions]()

Freyr partnered with a leading US-based biotechnology company to deliver end-to-end global regulatory publishing support across the US, EU, and RoW regions. With over 10 dedicated Publishing FTEs, Freyr established a unified global submissions process that accelerated IND filings and ensured seamless coordination across multiple programs and markets.

The team managed expedited, high-stakes submissions with turnaround times as low as 1–5 days, while adhering to the client’s SOPs, style guides, and technology systems. This strategic collaboration enabled rapid scale-up, improved submission quality, and supported successful regulatory approvals under stringent timelines.

**Download the full case study to explore the complete transformation.**



Fill the form below to download the Case Study

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name